Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Crea

Showing results (761-770 of 850) with videos related to

Pageof 85
Sort By:
Atherosclerosis|June 12, 2012
"In vivo" imaging of atherosclerosisAugusto Gallino, Matthias Stuber, Filippo Crea, et al.
American Heart Journal|March 19, 2023
Postoperative pericardial effusion, pericardiotomy, and atrial fibrillation: An explanatory analysis of the PALACS trialLisa Q Rong, Antonino Di Franco, Mohamed Rahouma, et al.
Journal of the American Heart Association|February 25, 2025
Sex-Related Differences in the Prognostic Role of Acetylcholine Provocation TestingRiccardo Rinaldi, Michele Russo, Giovanni Occhipinti, et al.
Minerva Cardiology and Angiology|February 27, 2023
Pre-stenting residual thrombotic volume assessed by dual quantitative coronary angiography predicts microvascular obstruction in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionRocco Vergallo, Marco Lombardi, Giorgos Besis, et al.
Cardio-Oncology (London, England)|March 27, 2024
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept studyMassimiliano Camilli, Marcello Viscovo, Tamara Felici, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 13, 2020
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) studyDomenico D'Amario, Mattia Galli, Francesco Canonico, et al.
Circulation|May 28, 2009
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial, John H Alexander, Richard C Becker, et al.
Frontiers in Cardiovascular Medicine|February 11, 2022
Monocyte-Platelet Aggregates Triggered by CD31 Molecule in Non-ST Elevation Myocardial Infarction: Clinical Implications in Plaque RuptureRamona Vinci, Daniela Pedicino, Alice Bonanni, et al.
Frontiers in Cardiovascular Medicine|September 5, 2022
Safety and effectiveness of post percutaneous coronary intervention physiological assessment: Retrospective data from the post-revascularization optimization and physiological evaluation of intermediate lesions using fractional flow reserve registryAntonio Maria Leone, Stefano Migliaro, Giuseppe Zimbardo, et al.
European Heart Journal. Digital Health|July 24, 2025
Study design and rationale of the AZIMUTH trial: a smartphone, app-based, E-health-integrated model of care for heart failure patientsDomenico D'Amario, Attilio Restivo, Renzo Laborante, et al.
Pageof 85

Showing results (761-770 of 850) with videos related to

Sort By:
Pageof 85
Atherosclerosis|June 12, 2012
"In vivo" imaging of atherosclerosisAugusto Gallino, Matthias Stuber, Filippo Crea, et al.
American Heart Journal|March 19, 2023
Postoperative pericardial effusion, pericardiotomy, and atrial fibrillation: An explanatory analysis of the PALACS trialLisa Q Rong, Antonino Di Franco, Mohamed Rahouma, et al.
Journal of the American Heart Association|February 25, 2025
Sex-Related Differences in the Prognostic Role of Acetylcholine Provocation TestingRiccardo Rinaldi, Michele Russo, Giovanni Occhipinti, et al.
Minerva Cardiology and Angiology|February 27, 2023
Pre-stenting residual thrombotic volume assessed by dual quantitative coronary angiography predicts microvascular obstruction in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionRocco Vergallo, Marco Lombardi, Giorgos Besis, et al.
Cardio-Oncology (London, England)|March 27, 2024
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept studyMassimiliano Camilli, Marcello Viscovo, Tamara Felici, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 13, 2020
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) studyDomenico D'Amario, Mattia Galli, Francesco Canonico, et al.
Circulation|May 28, 2009
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial, John H Alexander, Richard C Becker, et al.
Frontiers in Cardiovascular Medicine|February 11, 2022
Monocyte-Platelet Aggregates Triggered by CD31 Molecule in Non-ST Elevation Myocardial Infarction: Clinical Implications in Plaque RuptureRamona Vinci, Daniela Pedicino, Alice Bonanni, et al.
Frontiers in Cardiovascular Medicine|September 5, 2022
Safety and effectiveness of post percutaneous coronary intervention physiological assessment: Retrospective data from the post-revascularization optimization and physiological evaluation of intermediate lesions using fractional flow reserve registryAntonio Maria Leone, Stefano Migliaro, Giuseppe Zimbardo, et al.
European Heart Journal. Digital Health|July 24, 2025
Study design and rationale of the AZIMUTH trial: a smartphone, app-based, E-health-integrated model of care for heart failure patientsDomenico D'Amario, Attilio Restivo, Renzo Laborante, et al.
Pageof 85